These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2854071)

  • 1. Myo-inositol(1,4,5)trisphosphorothioate binds to specific [3H]inositol(1,4,5)trisphosphate sites in rat cerebellum and is resistant to 5-phosphatase.
    Willcocks AL; Potter BV; Cooke AM; Nahorski SR
    Eur J Pharmacol; 1988 Oct; 155(1-2):181-3. PubMed ID: 2854071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. myo-inositol 1,4,5-trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5-phosphatase.
    Cooke AM; Nahorski SR; Potter BV
    FEBS Lett; 1989 Jan; 242(2):373-7. PubMed ID: 2536622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-[35S(U)]inositol 1,4,5-trisphosphorothioate, a novel radioligand for the inositol 1,4,5-trisphosphate receptor. Complex binding to rat cerebellar membranes.
    Challiss RA; Smith SM; Potter BV; Nahorski SR
    FEBS Lett; 1991 Apr; 281(1-2):101-4. PubMed ID: 1849834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DL-myo-inositol 1,4,5-trisphosphorothioate mobilizes intracellular calcium in Swiss 3T3 cells and Xenopus oocytes.
    Taylor CW; Berridge MJ; Brown KD; Cooke AM; Potter BV
    Biochem Biophys Res Commun; 1988 Jan; 150(2):626-32. PubMed ID: 3342041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol 1,4,5-trisphosphorothioate, a stable analogue of inositol trisphosphate which mobilizes intracellular calcium.
    Taylor CW; Berridge MJ; Cooke AM; Potter BV
    Biochem J; 1989 May; 259(3):645-50. PubMed ID: 2786414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Lampe D; Liu C; Potter BV
    J Med Chem; 1994 Apr; 37(7):907-12. PubMed ID: 8151617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate.
    Strupish J; Cooke AM; Potter BV; Gigg R; Nahorski SR
    Biochem J; 1988 Aug; 253(3):901-5. PubMed ID: 3263119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of myo-inositol 1,4,5-trisphosphorothioate on Cl- current pattern and intracellular Ca2+ in the Xenopus laevis oocyte.
    Ferguson JE; Potter B; Nuccitelli R
    Biochem Biophys Res Commun; 1990 Oct; 172(1):229-36. PubMed ID: 1699536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
    Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate.
    Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR
    Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
    Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins.
    Hirata M; Yanaga F; Koga T; Ogasawara T; Watanabe Y; Ozaki S
    J Biol Chem; 1990 May; 265(15):8404-7. PubMed ID: 2160455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regiospecific phosphohydrolases from Dictyostelium as tools for the chemoenzymatic synthesis of the enantiomers D-myo-inositol 1,2,4-trisphosphate and D-myo-inositol 2,3,6-trisphosphate: non-physiological, potential analogues of biologically active D-myo-inositol 1,3,4-trisphosphate.
    Adelt S; Plettenburg O; Dallmann G; Ritter FP; Shears SB; Altenbach HJ; Vogel G
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2705-8. PubMed ID: 11591506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.